---
title: Molecular diagnostics of hepatobiliary and pancreatic neoplasias
date: '2024-03-01'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38429607/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240302170447&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Neoplasias of the hepatopancreatobiliary tract are growing in numbers,
  have the poorest prognosis of all major cancer entities, and thus represent a rising
  clinical problem. Their molecular diagnostic has dramatically improved, contributing
  to tumor subtyping, definition of malignancy, and uncovering cases with hereditary
  predisposition. Most of all, predictive molecular testing allows to identify cases
  amenable to treatment with the rising number of approved targeted drugs, immune-oncological...
  ...
disable_comments: true
---
Neoplasias of the hepatopancreatobiliary tract are growing in numbers, have the poorest prognosis of all major cancer entities, and thus represent a rising clinical problem. Their molecular diagnostic has dramatically improved, contributing to tumor subtyping, definition of malignancy, and uncovering cases with hereditary predisposition. Most of all, predictive molecular testing allows to identify cases amenable to treatment with the rising number of approved targeted drugs, immune-oncological... ...